Why nuclear weapons are more realistic for Europe than mass mobilization. We explore how strengthening Europe's arsenal will affect Russia's ability to wage war and what role the conventional forces ...

Dr. John Leite, our Chief Commercial Officer, and Dr. Phillip G. Febbo, our Chief Medical and Scientific Officer, will join ...

Voluntary premiums on policies written in the quarter were 10.5% higher than in the fourth quarter of 2024, primarily due to strong premium retention and consistent new business production. For the ...

Updated data for casdatifan in late-line kidney cancer demonstrated median progression-free survival (PFS) of 15.1 months and a confirmed overall response rate (cORR) of 45% for the 100mg once-daily ...

N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today reported results for its fourth quarter ended December 31, 2025.

agilon health's balance sheet as of December 31, 2025 included cash, cash equivalents and marketable securities of $285 million and total debt of $35 million. At the end of the quarter, agilon health ...